Key points are not available for this paper at this time.
The National Surgical Adjuvant Breast Project (NSABP) Protocol B-17 on intraductal carcinoma of the breast' shows a 67% difference in average annual hazard rates for local recurrence between patients treated by lumpectomy alone and
Antoniades et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: